Dyne Therapeutics Inc (DYN)
23.87
+0.22
(+0.93%)
USD |
NASDAQ |
Apr 19, 16:00
23.87
0.00 (0.00%)
After-Hours: 19:13
Dyne Therapeutics Shareholders Equity (Quarterly): 91.29M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 91.29M |
| September 30, 2023 | 152.04M |
| June 30, 2023 | 206.88M |
| March 31, 2023 | 241.94M |
| December 31, 2022 | 252.36M |
| September 30, 2022 | 249.74M |
| June 30, 2022 | 287.06M |
| March 31, 2022 | 336.46M |
| Date | Value |
|---|---|
| December 31, 2021 | 368.20M |
| September 30, 2021 | 414.12M |
| June 30, 2021 | 452.60M |
| March 31, 2021 | 478.26M |
| December 31, 2020 | 342.37M |
| September 30, 2020 | 366.84M |
| June 30, 2020 | 132.48M |
| December 31, 2019 | 14.04M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
14.04M
Minimum
Dec 2019
478.26M
Maximum
Mar 2021
274.17M
Average
269.71M
Median
Shareholders Equity (Quarterly) Benchmarks
| Rocket Pharmaceuticals Inc | 492.57M |
| Solid Biosciences Inc | 126.48M |
| Avidity Biosciences Inc | 500.76M |
| Sana Biotechnology Inc | 287.51M |
| Tenaya Therapeutics Inc | 139.42M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 165.08M |
| Total Liabilities (Quarterly) | 73.79M |